SteelPeak Wealth’s Quest Diagnostics DGX Stock Holding History

SteelPeak Wealth’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Buy	1,446 +68	+5%	+$13.3K	0.01%	518
2026 Q1	$270K	Buy	1,378 +149	+12%	+$28.9K	0.01%	477
2025 Q4	$213K	Sell	1,229 -23	-2%	-$4.19K	0.01%	488
2025 Q3	$239K	Sell	1,252 -13,705	-92%	-$2.43M	0.01%	508
2025 Q2	$2.69M	Buy	14,957 +268	+2%	+$46.5K	0.1%	151
2025 Q1	$2.49M	Buy	+14,689	New	+$2.41M	0.1%	156
2023 Q2	–	Sell	-16,477	Closed	-$2.33M	–	462
2023 Q1	$2.33M	Buy	+16,477	New	+$2.36M	0.16%	101
2022 Q4	–	Sell	-15,044	Closed	-$1.85M	–	436
2022 Q3	$1.85M	Sell	15,044 -252	-2%	-$33.2K	0.14%	120
2022 Q2	$2.03M	Buy	+15,296	New	+$2.08M	0.15%	111

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

SteelPeak Wealth's DGX Position: Q2 2026 in Review

SteelPeak Wealth increased its Quest Diagnostics (DGX) stake by 4.9% in Q2 2026, buying an estimated $13.3K and bringing the position to 1,446 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #518.

SteelPeak Wealth first reported a position in DGX in Q2 2022 and has held it in 9 quarters since. The position peaked at $2.69M in Q2 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

SteelPeak Wealth held 1,446 shares of Quest Diagnostics worth $306K as of Q2 2026.
SteelPeak Wealth bought 68 Quest Diagnostics shares in Q2 2026, an estimated $13.3K.
Quest Diagnostics made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #518 holding.
SteelPeak Wealth first reported a position in Quest Diagnostics in Q2 2022 and has held it in 9 quarters since.
SteelPeak Wealth's Quest Diagnostics position peaked at $2.69M in Q2 2025.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.